Organon & Co - Company Profile
Powered by
All the data and insights you need on Organon & Co in one report.
$295
- Save hours of research time and resources with
our up-to-date Organon & Co Strategy Report
- Understand Organon & Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Organon & Co’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
21 Jul 2023 | Organon & Co Enters Phase III Clinical Trial Agreement with IQVIA Holdings Inc for (desogestrel + ethinylestradiol) (GDCT0494691) | Contract Service Agreement |
Organon & Co
|
IQVIA Holdings Inc |
13 Mar 2023 | Organon & Co Enters Phase IV Clinical Trial Agreement with IQVIA Holdings Inc for (atorvastatin calcium + ezetimibe) (GDCT0481591) | Contract Service Agreement |
Organon & Co
|
IQVIA Holdings Inc |
05 Jan 2023 | Organon to Acquire Claria Medical | Acquisition |
Organon & Co
|
Claria Medical Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer